Global Immunology Market Overview:
Global Immunology Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Immunology Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Immunology involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Immunology Market:
The Immunology Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Immunology Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Immunology Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Immunology market has been segmented into:
Checkpoint Inhibitors
Adoptive Cell Therapy
Oncolytic Viruses
Cancer Vaccines
Immunomodulators
By Application, Immunology market has been segmented into:
Cancer
Autoimmune Diseases
Infectious Diseases
Neurological Disorders
Allergic Diseases
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Immunology market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Immunology market.
Top Key Players Covered in Immunology market are:
Merck KGaA
Thermo Fisher Scientific
Sysmex Corporation
QIAGEN
Abbott Laboratories
Danaher Corporation
Beckman Coulter Inc
Siemens Healthineers AG
BD (Becton
Dickinson and Company)
BioRad Laboratories
Agilent Technologies Inc
HoffmannLa Roche Ltd.
Olympus Corporation
PerkinElmer Inc
BioMérieux SA
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Immunology Market Type
4.1 Immunology Market Snapshot and Growth Engine
4.2 Immunology Market Overview
4.3 Checkpoint Inhibitors
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Checkpoint Inhibitors: Geographic Segmentation Analysis
4.4 Adoptive Cell Therapy
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Adoptive Cell Therapy: Geographic Segmentation Analysis
4.5 Oncolytic Viruses
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Oncolytic Viruses: Geographic Segmentation Analysis
4.6 Cancer Vaccines
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Cancer Vaccines: Geographic Segmentation Analysis
4.7 Immunomodulators
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Immunomodulators: Geographic Segmentation Analysis
Chapter 5: Immunology Market Application
5.1 Immunology Market Snapshot and Growth Engine
5.2 Immunology Market Overview
5.3 Cancer
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Cancer: Geographic Segmentation Analysis
5.4 Autoimmune Diseases
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Autoimmune Diseases: Geographic Segmentation Analysis
5.5 Infectious Diseases
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Infectious Diseases: Geographic Segmentation Analysis
5.6 Neurological Disorders
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Neurological Disorders: Geographic Segmentation Analysis
5.7 Allergic Diseases
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Allergic Diseases: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Immunology Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 MERCK KGAA
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 THERMO FISHER SCIENTIFIC
6.4 SYSMEX CORPORATION
6.5 QIAGEN
6.6 ABBOTT LABORATORIES
6.7 DANAHER CORPORATION
6.8 BECKMAN COULTER INC
6.9 SIEMENS HEALTHINEERS AG
6.10 BD (BECTON
6.11 DICKINSON AND COMPANY)
6.12 BIORAD LABORATORIES
6.13 AGILENT TECHNOLOGIES INC
6.14 HOFFMANNLA ROCHE LTD.
6.15 OLYMPUS CORPORATION
6.16 PERKINELMER INC
6.17 BIOMÉRIEUX SA
Chapter 7: Global Immunology Market By Region
7.1 Overview
7.2. North America Immunology Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Checkpoint Inhibitors
7.2.2.2 Adoptive Cell Therapy
7.2.2.3 Oncolytic Viruses
7.2.2.4 Cancer Vaccines
7.2.2.5 Immunomodulators
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Cancer
7.2.3.2 Autoimmune Diseases
7.2.3.3 Infectious Diseases
7.2.3.4 Neurological Disorders
7.2.3.5 Allergic Diseases
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Immunology Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Checkpoint Inhibitors
7.3.2.2 Adoptive Cell Therapy
7.3.2.3 Oncolytic Viruses
7.3.2.4 Cancer Vaccines
7.3.2.5 Immunomodulators
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Cancer
7.3.3.2 Autoimmune Diseases
7.3.3.3 Infectious Diseases
7.3.3.4 Neurological Disorders
7.3.3.5 Allergic Diseases
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Immunology Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Checkpoint Inhibitors
7.4.2.2 Adoptive Cell Therapy
7.4.2.3 Oncolytic Viruses
7.4.2.4 Cancer Vaccines
7.4.2.5 Immunomodulators
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Cancer
7.4.3.2 Autoimmune Diseases
7.4.3.3 Infectious Diseases
7.4.3.4 Neurological Disorders
7.4.3.5 Allergic Diseases
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Immunology Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Checkpoint Inhibitors
7.5.2.2 Adoptive Cell Therapy
7.5.2.3 Oncolytic Viruses
7.5.2.4 Cancer Vaccines
7.5.2.5 Immunomodulators
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Cancer
7.5.3.2 Autoimmune Diseases
7.5.3.3 Infectious Diseases
7.5.3.4 Neurological Disorders
7.5.3.5 Allergic Diseases
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Immunology Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Checkpoint Inhibitors
7.6.2.2 Adoptive Cell Therapy
7.6.2.3 Oncolytic Viruses
7.6.2.4 Cancer Vaccines
7.6.2.5 Immunomodulators
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Cancer
7.6.3.2 Autoimmune Diseases
7.6.3.3 Infectious Diseases
7.6.3.4 Neurological Disorders
7.6.3.5 Allergic Diseases
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Immunology Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Checkpoint Inhibitors
7.7.2.2 Adoptive Cell Therapy
7.7.2.3 Oncolytic Viruses
7.7.2.4 Cancer Vaccines
7.7.2.5 Immunomodulators
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Cancer
7.7.3.2 Autoimmune Diseases
7.7.3.3 Infectious Diseases
7.7.3.4 Neurological Disorders
7.7.3.5 Allergic Diseases
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Immunology Scope:
|
Report Data
|
Immunology Market
|
|
Immunology Market Size in 2025
|
USD XX million
|
|
Immunology CAGR 2025 - 2032
|
XX%
|
|
Immunology Base Year
|
2024
|
|
Immunology Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Merck KGaA, Thermo Fisher Scientific, Sysmex Corporation, QIAGEN, Abbott Laboratories, Danaher Corporation, Beckman Coulter Inc, Siemens Healthineers AG, BD (Becton, Dickinson and Company), BioRad Laboratories, Agilent Technologies Inc, HoffmannLa Roche Ltd., Olympus Corporation, PerkinElmer Inc, BioMérieux SA.
|
|
Key Segments
|
By Type
Checkpoint Inhibitors
Adoptive Cell Therapy
Oncolytic Viruses
Cancer Vaccines
Immunomodulators
By Applications
Cancer
Autoimmune Diseases
Infectious Diseases
Neurological Disorders
Allergic Diseases
|
